Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1
1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina d...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2009-04, Vol.296 (4), p.R952-R959 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | R959 |
---|---|
container_issue | 4 |
container_start_page | R952 |
container_title | American journal of physiology. Regulatory, integrative and comparative physiology |
container_volume | 296 |
creator | Sachidanandam, Kamakshi Hutchinson, Jim R Elgebaly, Mostafa M Mezzetti, Erin M Dorrance, Anne M Motamed, Kouros Ergul, Adviye |
description | 1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina del Rey, California
Submitted 26 June 2008
; accepted in final form 23 January 2009
Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET A receptors, whereas blockade of ET B receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET A receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET A receptors alter vascular structure and mechanics in Type 2 diabetes.
vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors
Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912 |
doi_str_mv | 10.1152/ajpregu.90537.2008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_229747702</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67077997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-a7fa4f297ffc70fdb648762f70eb9bd184ea092d6b7bb3ec0f8d5d04f778003a3</originalsourceid><addsrcrecordid>eNpdkV-L1DAUxYso7uzqF_BBgg--dbxJ2qbxQVgWXYUFQdbnkDa3bcY2GZN2pN_ezM6w_nkKyfndwz05WfaKwpbSkr3Tu33AftlKKLnYMoD6SbZJAstpIeFptgFe8byiVF5klzHuAKDgBX-eXVBJRVVL2GTudlxbnGxLWu_m4EeSPA_o5kjSY_AHHdtl1IEEnLzB0bqeaGeIdW1AHdGQ2TtMV3K_7pEwYqxucMb4niT2R1IJOuPn4Tia0xfZs06PEV-ez6vs-6eP9zef87uvt19uru_ytuR0zrXodNExKbquFdCZpipqUbFOADayMbQuUINkpmpE03BsoatNaaDohKgBuOZX2YeT735pJjRtChT0qPbBTjqsymur_lWcHVTvD4pVsq6AJoO3Z4Pgfy4YZzXZ2OI4aod-iaoSIISUIoFv_gN3fgkuhVMsBSiEAJYgdoLSj8YYsHvchII6dqnOXaqHLtWxyzT0-u8Mf0bO5SUgPwGD7YdfNqDaD2u0fvT9-mjIZKUK9U2WjP8GqEqvjA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229747702</pqid></control><display><type>article</type><title>Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1</title><source>MEDLINE</source><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sachidanandam, Kamakshi ; Hutchinson, Jim R ; Elgebaly, Mostafa M ; Mezzetti, Erin M ; Dorrance, Anne M ; Motamed, Kouros ; Ergul, Adviye</creator><creatorcontrib>Sachidanandam, Kamakshi ; Hutchinson, Jim R ; Elgebaly, Mostafa M ; Mezzetti, Erin M ; Dorrance, Anne M ; Motamed, Kouros ; Ergul, Adviye</creatorcontrib><description>1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina del Rey, California
Submitted 26 June 2008
; accepted in final form 23 January 2009
Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET A receptors, whereas blockade of ET B receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET A receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET A receptors alter vascular structure and mechanics in Type 2 diabetes.
vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors
Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912 (e-mail: aergul{at}mcg.edu )</description><identifier>ISSN: 0363-6119</identifier><identifier>EISSN: 1522-1490</identifier><identifier>DOI: 10.1152/ajpregu.90537.2008</identifier><identifier>PMID: 19176890</identifier><identifier>CODEN: AJPRDO</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Blood Glucose - drug effects ; Blood Glucose - metabolism ; Collagen - metabolism ; Diabetes ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - physiopathology ; Disease Models, Animal ; Endocrinology ; Endothelin-1 - metabolism ; Glucose ; Hyperplasia ; Hypoglycemic Agents - pharmacology ; Male ; Matrix Metalloproteinase 13 - metabolism ; Mesenteric Arteries - drug effects ; Mesenteric Arteries - metabolism ; Mesenteric Arteries - pathology ; Mesenteric Arteries - physiopathology ; Metabolism ; Metformin - pharmacology ; Microvessels - drug effects ; Microvessels - metabolism ; Microvessels - physiopathology ; Proteins ; Rats ; Rats, Wistar ; Receptor, Endothelin A - metabolism ; Receptor, Endothelin B - metabolism ; Receptors and Signaling Pathways ; Rodents ; Vasoconstriction - drug effects ; Veins & arteries</subject><ispartof>American journal of physiology. Regulatory, integrative and comparative physiology, 2009-04, Vol.296 (4), p.R952-R959</ispartof><rights>Copyright American Physiological Society Apr 2009</rights><rights>Copyright © 2009, American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-a7fa4f297ffc70fdb648762f70eb9bd184ea092d6b7bb3ec0f8d5d04f778003a3</citedby><cites>FETCH-LOGICAL-c531t-a7fa4f297ffc70fdb648762f70eb9bd184ea092d6b7bb3ec0f8d5d04f778003a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3037,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19176890$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sachidanandam, Kamakshi</creatorcontrib><creatorcontrib>Hutchinson, Jim R</creatorcontrib><creatorcontrib>Elgebaly, Mostafa M</creatorcontrib><creatorcontrib>Mezzetti, Erin M</creatorcontrib><creatorcontrib>Dorrance, Anne M</creatorcontrib><creatorcontrib>Motamed, Kouros</creatorcontrib><creatorcontrib>Ergul, Adviye</creatorcontrib><title>Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1</title><title>American journal of physiology. Regulatory, integrative and comparative physiology</title><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><description>1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina del Rey, California
Submitted 26 June 2008
; accepted in final form 23 January 2009
Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET A receptors, whereas blockade of ET B receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET A receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET A receptors alter vascular structure and mechanics in Type 2 diabetes.
vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors
Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912 (e-mail: aergul{at}mcg.edu )</description><subject>Animals</subject><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Collagen - metabolism</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Disease Models, Animal</subject><subject>Endocrinology</subject><subject>Endothelin-1 - metabolism</subject><subject>Glucose</subject><subject>Hyperplasia</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Male</subject><subject>Matrix Metalloproteinase 13 - metabolism</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Mesenteric Arteries - metabolism</subject><subject>Mesenteric Arteries - pathology</subject><subject>Mesenteric Arteries - physiopathology</subject><subject>Metabolism</subject><subject>Metformin - pharmacology</subject><subject>Microvessels - drug effects</subject><subject>Microvessels - metabolism</subject><subject>Microvessels - physiopathology</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptor, Endothelin A - metabolism</subject><subject>Receptor, Endothelin B - metabolism</subject><subject>Receptors and Signaling Pathways</subject><subject>Rodents</subject><subject>Vasoconstriction - drug effects</subject><subject>Veins & arteries</subject><issn>0363-6119</issn><issn>1522-1490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV-L1DAUxYso7uzqF_BBgg--dbxJ2qbxQVgWXYUFQdbnkDa3bcY2GZN2pN_ezM6w_nkKyfndwz05WfaKwpbSkr3Tu33AftlKKLnYMoD6SbZJAstpIeFptgFe8byiVF5klzHuAKDgBX-eXVBJRVVL2GTudlxbnGxLWu_m4EeSPA_o5kjSY_AHHdtl1IEEnLzB0bqeaGeIdW1AHdGQ2TtMV3K_7pEwYqxucMb4niT2R1IJOuPn4Tia0xfZs06PEV-ez6vs-6eP9zef87uvt19uru_ytuR0zrXodNExKbquFdCZpipqUbFOADayMbQuUINkpmpE03BsoatNaaDohKgBuOZX2YeT735pJjRtChT0qPbBTjqsymur_lWcHVTvD4pVsq6AJoO3Z4Pgfy4YZzXZ2OI4aod-iaoSIISUIoFv_gN3fgkuhVMsBSiEAJYgdoLSj8YYsHvchII6dqnOXaqHLtWxyzT0-u8Mf0bO5SUgPwGD7YdfNqDaD2u0fvT9-mjIZKUK9U2WjP8GqEqvjA</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Sachidanandam, Kamakshi</creator><creator>Hutchinson, Jim R</creator><creator>Elgebaly, Mostafa M</creator><creator>Mezzetti, Erin M</creator><creator>Dorrance, Anne M</creator><creator>Motamed, Kouros</creator><creator>Ergul, Adviye</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090401</creationdate><title>Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1</title><author>Sachidanandam, Kamakshi ; Hutchinson, Jim R ; Elgebaly, Mostafa M ; Mezzetti, Erin M ; Dorrance, Anne M ; Motamed, Kouros ; Ergul, Adviye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-a7fa4f297ffc70fdb648762f70eb9bd184ea092d6b7bb3ec0f8d5d04f778003a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Collagen - metabolism</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Disease Models, Animal</topic><topic>Endocrinology</topic><topic>Endothelin-1 - metabolism</topic><topic>Glucose</topic><topic>Hyperplasia</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Male</topic><topic>Matrix Metalloproteinase 13 - metabolism</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Mesenteric Arteries - metabolism</topic><topic>Mesenteric Arteries - pathology</topic><topic>Mesenteric Arteries - physiopathology</topic><topic>Metabolism</topic><topic>Metformin - pharmacology</topic><topic>Microvessels - drug effects</topic><topic>Microvessels - metabolism</topic><topic>Microvessels - physiopathology</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptor, Endothelin A - metabolism</topic><topic>Receptor, Endothelin B - metabolism</topic><topic>Receptors and Signaling Pathways</topic><topic>Rodents</topic><topic>Vasoconstriction - drug effects</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sachidanandam, Kamakshi</creatorcontrib><creatorcontrib>Hutchinson, Jim R</creatorcontrib><creatorcontrib>Elgebaly, Mostafa M</creatorcontrib><creatorcontrib>Mezzetti, Erin M</creatorcontrib><creatorcontrib>Dorrance, Anne M</creatorcontrib><creatorcontrib>Motamed, Kouros</creatorcontrib><creatorcontrib>Ergul, Adviye</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sachidanandam, Kamakshi</au><au>Hutchinson, Jim R</au><au>Elgebaly, Mostafa M</au><au>Mezzetti, Erin M</au><au>Dorrance, Anne M</au><au>Motamed, Kouros</au><au>Ergul, Adviye</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1</atitle><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>296</volume><issue>4</issue><spage>R952</spage><epage>R959</epage><pages>R952-R959</pages><issn>0363-6119</issn><eissn>1522-1490</eissn><coden>AJPRDO</coden><abstract>1 Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, 2 Department of Physiology, Medical College of Georgia, Augusta, Georgia; 3 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan; and 4 Abraxis BioScience, Marina del Rey, California
Submitted 26 June 2008
; accepted in final form 23 January 2009
Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of Type 1 diabetes in vascular remodeling, we recently extended these observations to Type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET A receptors, whereas blockade of ET B receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for Type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET A receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET A receptors alter vascular structure and mechanics in Type 2 diabetes.
vascular remodeling; vascular compliance; glycemic control; extracellular matrix; endothelin receptors
Address for reprint requests and other correspondence: A. Ergul, Medical College of Georgia, 1120 15th St., CA 2094, Augusta, GA 30912 (e-mail: aergul{at}mcg.edu )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>19176890</pmid><doi>10.1152/ajpregu.90537.2008</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-6119 |
ispartof | American journal of physiology. Regulatory, integrative and comparative physiology, 2009-04, Vol.296 (4), p.R952-R959 |
issn | 0363-6119 1522-1490 |
language | eng |
recordid | cdi_proquest_journals_229747702 |
source | MEDLINE; American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Blood Glucose - drug effects Blood Glucose - metabolism Collagen - metabolism Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - physiopathology Disease Models, Animal Endocrinology Endothelin-1 - metabolism Glucose Hyperplasia Hypoglycemic Agents - pharmacology Male Matrix Metalloproteinase 13 - metabolism Mesenteric Arteries - drug effects Mesenteric Arteries - metabolism Mesenteric Arteries - pathology Mesenteric Arteries - physiopathology Metabolism Metformin - pharmacology Microvessels - drug effects Microvessels - metabolism Microvessels - physiopathology Proteins Rats Rats, Wistar Receptor, Endothelin A - metabolism Receptor, Endothelin B - metabolism Receptors and Signaling Pathways Rodents Vasoconstriction - drug effects Veins & arteries |
title | Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A22%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycemic%20control%20prevents%20microvascular%20remodeling%20and%20increased%20tone%20in%20Type%202%20diabetes:%20link%20to%20endothelin-1&rft.jtitle=American%20journal%20of%20physiology.%20Regulatory,%20integrative%20and%20comparative%20physiology&rft.au=Sachidanandam,%20Kamakshi&rft.date=2009-04-01&rft.volume=296&rft.issue=4&rft.spage=R952&rft.epage=R959&rft.pages=R952-R959&rft.issn=0363-6119&rft.eissn=1522-1490&rft.coden=AJPRDO&rft_id=info:doi/10.1152/ajpregu.90537.2008&rft_dat=%3Cproquest_pubme%3E67077997%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229747702&rft_id=info:pmid/19176890&rfr_iscdi=true |